Viekira Pak Induced Fatal Lactic Acidosis: A Case Report of an Unusual Side Effect

Viekira Pak is a new direct-acting antiviral agent that has an excellent efficacy in treating patients with chronic HCV. FDA released a safety warning that Viekira Pak can cause serious liver injury mostly in patients with underlying advanced liver disease. We report the first case of fatal lactic a...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdulsamad, Molham, Ihimoyan, Ariyo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5156790/
https://www.ncbi.nlm.nih.gov/pubmed/28044114
http://dx.doi.org/10.1155/2016/8627139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5156790/
https://www.ncbi.nlm.nih.gov/pubmed/28044114
http://dx.doi.org/10.1155/2016/8627139

Ejemplares similares